UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12Aaron Lee, Adnan Tufail, Toks Akerele et al.|British Journal of Ophthalmology|2015Cited by 60
UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practiceAaron Lee, Adnan Tufail, Cecilia S. Lee et al.|British Journal of Ophthalmology|2017Cited by 47
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic RetinopathyCecilia S. Lee, Aaron Lee, Douglas M. Baughman et al.|American Journal of Ophthalmology|2017Cited by 47
VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINEDCecilia S. Lee, Adnan Tufail, Alisa J. Kim et al.|Retina|2017Cited by 12